Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does TMAO reflect gut microbial conversion of dietary precursors followed by liver oxidation?

TMAO is produced through gut microbial conversion of dietary precursors to trimethylamine and subsequent liver oxidation to TMAO.

PlausibleSeptember 30, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Trimethylamine N-oxide reflects gut microbial conversion of dietary precursors to trimethylamine, followed by liver oxidation to trimethylamine N-oxide.

laying out figure…
3 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim describes a sequential host–microbiome pathway in which dietary nutrients are first converted by intestinal microbes into trimethylamine. The mechanism graph frames TMAO as the downstream product of this process, shaped mainly by liver oxidation, with circulating levels also influenced by FMO3 activity and renal clearance.

Verified conclusion

TMAO is produced through a well-established host–microbiome pathway: dietary nutrients are converted by intestinal microbes to trimethylamine (TMA), then oxidized predominantly in the liver to TMAO.

Clinical and human mechanistic evidence

  • Human stable-isotope studies provide direct support for this sequence. After deuterium-labeled phosphatidylcholine given with eggs, labeled TMAO appeared in plasma and urine; ciprofloxacin plus metronidazole nearly eliminated both labeled and native TMAO, with production returning after antibiotics were stopped.
  • Similar results followed labeled L-carnitine with a steak challenge: labeled TMAO was detected in plasma and 24-hour urine, was nearly abolished during broad-spectrum antibiotic exposure, and recovered after microbiota restoration.
  • These experiments establish that an intact gut microbiota is necessary for conversion of these dietary precursors into the TMAO-producing pathway.

Mechanistic interpretation

  • Gut microbes generate TMA from multiple dietary precursors, including phosphatidylcholine and L-carnitine. For L-carnitine, γ-butyrobetaine is a documented intermediate before microbial TMA formation.
  • TMA is then oxidized mainly by hepatic flavin-containing monooxygenase 3 (FMO3) to TMAO. The tracer findings strongly fit this sequential mechanism, although those studies inferred rather than directly measured hepatic FMO3 flux.
  • Measured circulating TMAO is not a microbiome-specific measure: FMO3 activity and renal elimination also materially influence concentration. Reduced kidney clearance can raise circulating TMAO independently of increased microbial production.

Bottom line

  • The claim is strongly supported: TMAO reflects microbial conversion of dietary precursors to TMA followed principally by liver FMO3-mediated oxidation. In practice, however, a TMAO level integrates diet, microbial metabolic capacity, hepatic FMO3 activity, and kidney clearance rather than isolating any one of these processes.

References

  1. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk | NEJM — nejm.org ↗
  2. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat ... — pmc.ncbi.nlm.nih.gov ↗
  3. The Journal of Clinical Investigation — dm5migu4zj3pb.cloudfront.net ↗
  4. Trimethylamine-N-Oxide, a Metabolite Associated with ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  5. Mediated Host-Microbiome Metabolic Axis Implicated in Health and ... — pmc.ncbi.nlm.nih.gov ↗
  6. TMAO as a potential biomarker and therapeutic target for chronic kidney ... — pmc.ncbi.nlm.nih.gov ↗
  7. Microbiome-Derived Trimethylamine N-Oxide (TMAO) as a ... — pmc.ncbi.nlm.nih.gov ↗
  8. Trimethylamine N-Oxide as a Potential Biomarker for ... - PMC — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible6 sourcesDoes a normal TMAO concentration reflect the overall balance of intake, microbial production, liver oxidation, and kidney elimination?→Plausible5 sourcesIs TMAO produced by gut microbes and then oxidized by the liver?→